Characteristic | Total | Bloodstream infection | P value | |
---|---|---|---|---|
Yes | No | |||
Number of patients | 712 | 55 | 657 | NA |
Demographics | ||||
Age, median (IQR), yrs | 52 (33–65) | 56 (38–66) | 52 (33–65) | 0.201 |
Male sex | 364 (51.1) | 29 (52.7) | 335 (51.0) | 0.804 |
Final diagnosis | ||||
Infectious disease | 366 (51.4) | 55 (100) | 311 (47.3) | NA |
NIID | 203 (28.5) | NA | 203 (30.9) | NA |
Malignanciesa | 52 (7.3) | NA | 52 (7.9) | NA |
Other and unknown | 91 (12.8) | NA | 91 (13.9) | NA |
Comorbidity | ||||
Diabetes mellitus | 72 (10.1) | 17 (30.9) | 55 (8.4) | 0.000 |
Liver cirrhosis | 12 (1.7) | 4 (7.3) | 8 (1.2) | 0.001 |
Chronic kidney disease | 14 (2.0) | 3 (5.5) | 11 (1.7) | 0.062 |
Solid tumor | 24 (3.4) | 7 (12.7) | 17 (2.6) | 0.001 |
Hematological malignancy | 7 (1.0) | 1 (1.8) | 6 (0.9) | 0.432 |
Other underlying condition | ||||
Corticosteroid useb | 17 (2.4) | 3 (5.5) | 14 (2.1) | 0.137 |
Chemotherapyb | 9 (1.3) | 2 (3.6) | 7 (1.1) | 0.149 |
Invasive procedureb | 63 (8.8) | 9 (16.4) | 54 (8.2) | 0.049 |
Catheter use | 15 (2.1) | 4 (7.3) | 11 (1.7) | 0.023 |
Implant device | 12 (1.7) | 4 (7.3) | 8 (1.2) | 0.010 |
Clinical feature | ||||
Highest temperature, median (IQR), ℃ | 39.2 (38.8–39.9) | 39.5 (39.0–40.0) | 39.2 (38.8–39.8) | 0.004 |
Chills | 208 (29.2) | 32 (58.2) | 176 (26.8) | 0.000 |
Outcome | ||||
In-hospital mortality | 0 (0) | 0 (0) | 0 (0) | NA |
LOS, median (IQR), d | 11 (7–17) | 14 (10–21) | 11 (7–17) | 0.004 |